St. John’s Wort, a popular herbal supplement used for mild depression, can significantly interact with antidepressants, potentially reducing their effectiveness or causing serotonin syndrome.
Major interaction risk with SSRIs (e.g., fluoxetine, sertraline), SNRIs (e.g., venlafaxine), and TCAs; monitor plasma levels if unavoidable.
Onset of induction effects can persist up to 2 weeks after stopping St. John’s Wort.
Patients should inform providers of all supplements to prevent unintended interactions.
Not recommended for those with depression due to unreliable efficacy and risks.
St. John’s Wort induces cytochrome P450 enzymes (primarily CYP3A4, CYP2C9, and CYP1A2), accelerating the metabolism of many antidepressants and lowering their blood levels. Additionally, it inhibits serotonin reuptake and monoamine oxidase, potentiating serotonergic effects when combined with SSRIs, SNRIs, or MAOIs.
Reduced therapeutic efficacy of antidepressants leading to treatment failure; increased risk of serotonin syndrome (symptoms: agitation, confusion, rapid heart rate, tremors); possible breakthrough depression or withdrawal symptoms.
Avoid concurrent use of St. John’s Wort with antidepressants. If already taking the supplement, discontinue it at least 2 weeks prior to starting antidepressants and monitor for changes in mood or side effects. Consult a healthcare provider for alternative therapies.
Was this helpful?
The content on SafeTo is for informational purposes only and does not constitute medical, veterinary, or professional advice. Always consult with a qualified professional for specific concerns.
